127 related articles for article (PubMed ID: 35167885)
21. Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.
Zhang J; Shi Q; Qu T; Zhou D; Cai T
Int J Pharm; 2021 Dec; 610():121235. PubMed ID: 34743960
[TBL] [Abstract][Full Text] [Related]
22. Oxymatrine-fatty acid deep eutectic solvents as novel penetration enhancers for transdermal drug delivery: Formation mechanism and enhancing effect.
Li B; Xiao T; Guo S; Wu Y; Lai R; Liu Z; Luo W; Xu Y
Int J Pharm; 2023 Apr; 637():122880. PubMed ID: 36958612
[TBL] [Abstract][Full Text] [Related]
23. Complexation of Apigenin and Oxymatrine Leading to Enhanced Anti-inflammatory Activity.
Yuan D; Wang Z; Li B; Li X; Wang Y; Wang X; Cao J; Guo Y; Du H; Lu S
J Nat Prod; 2023 May; 86(5):1179-1188. PubMed ID: 37115657
[TBL] [Abstract][Full Text] [Related]
24. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin.
Wei Y; Zhou S; Hao T; Zhang J; Gao Y; Qian S
Eur J Pharm Sci; 2019 Mar; 129():21-30. PubMed ID: 30590119
[TBL] [Abstract][Full Text] [Related]
25. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
26. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.
Yue PF; Yuan HL; Li XY; Yang M; Zhu WF
Int J Pharm; 2010 Mar; 387(1-2):139-46. PubMed ID: 20005937
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
[TBL] [Abstract][Full Text] [Related]
28. Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica.
Budiman A; Higashi K; Ueda K; Moribe K
Int J Pharm; 2021 May; 600():120492. PubMed ID: 33744448
[TBL] [Abstract][Full Text] [Related]
29. A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine.
Cao FH; OuYang WQ; Wang YP; Yue PF; Li SP
Arch Pharm Res; 2011 Apr; 34(4):551-62. PubMed ID: 21544720
[TBL] [Abstract][Full Text] [Related]
30. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation.
Pandya P; Gattani S; Jain P; Khirwal L; Surana S
AAPS PharmSciTech; 2008; 9(4):1247-52. PubMed ID: 19115110
[TBL] [Abstract][Full Text] [Related]
31. The natural bile acid surfactant sodium taurocholate (NaTC) as a coformer in coamorphous systems: Enhanced physical stability and dissolution behavior of coamorphous drug-NaTc systems.
Gniado K; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2018 Jan; 535(1-2):132-139. PubMed ID: 29107615
[TBL] [Abstract][Full Text] [Related]
32. Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.
Hatanaka Y; Uchiyama H; Kaneko S; Ueda K; Higashi K; Moribe K; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
Mol Pharm; 2023 Aug; 20(8):4071-4085. PubMed ID: 37498232
[TBL] [Abstract][Full Text] [Related]
33. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro].
Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L
Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137
[TBL] [Abstract][Full Text] [Related]
34. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
35. Rational Design of a Famotidine-Ibuprofen Coamorphous System: An Experimental and Theoretical Study.
Russo MG; Baldoni HA; Dávila YA; Brusau EV; Ellena JA; Narda GE
J Phys Chem B; 2018 Sep; 122(37):8772-8782. PubMed ID: 30160964
[TBL] [Abstract][Full Text] [Related]
36. Ball-Milling Preparation of the Drug-Drug Solid Form of Pioglitazone-Rosuvastatin at Different Molar Ratios: Characterization and Intrinsic Dissolution Rates Evaluation.
Muñoz Tecocoatzi MF; Páez-Franco JC; Rubio-Carrasco K; Núñez-Pineda A; Dorazco-González A; Fuentes-Noriega I; Vilchis-Néstor AR; Olvera LI; Morales-Morales D; Germán-Acacio JM
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839951
[TBL] [Abstract][Full Text] [Related]
37. Resonance Raman spectroscopic and density functional theoretical study on microsolvated 2-Thiocytosine clusters with polar solvents.
Deng Y; Liu X; Zhao Y; Xue J; Zheng X
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Apr; 230():118043. PubMed ID: 31951865
[TBL] [Abstract][Full Text] [Related]
38. Development of an osmotically-driven pellet coated with acrylic copolymers (Eudragit® RS 30 D) for the sustained release of oxymatrine, a freely water soluble drug used to treat stress ulcers (I): in vitro and in vivo evaluation in rabbits.
Piao H; Liu S; Piao H; Li X; Cui F
Drug Dev Ind Pharm; 2013 Aug; 39(8):1230-7. PubMed ID: 22873131
[TBL] [Abstract][Full Text] [Related]
39. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
[TBL] [Abstract][Full Text] [Related]
40. Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights.
Pardhi E; Tomar DS; Khemchandani R; Bazaz MR; Dandekar MP; Samanthula G; Singh SB; Mehra NK
J Biomol Struct Dyn; 2024 Feb; ():1-30. PubMed ID: 38299571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
